Effects of Synthetic Human Pancreatic Polypeptide, Synthetic Bovine Pancreatic Polypeptide, and the C-Terminal Hexapeptide on Pancreatic Somatostatin and Glucagon Secretion in the Rat

Synthetic human pancreatic polypeptide stimulated pancreatic somatostatin secretion by isolated rat islets and by the isolated perfused rat pancreas. In contrast, synthetic bovine pancreatic polypeptide and the C-terminal hexapeptide had no effect on somatostatin secretion. Synthetic human pancreatic polypeptide had only a mild stimulatory effect on glucagon secretion at the highest concentration of the peptide used (2.2 × 10−6 M) and in the presence of 16.7 mM glucose.

[1]  J. Rahier,et al.  Long cytoplasmic processes in pancreatic polypeptide cells , 2004, Cell and Tissue Research.

[2]  F. Sundler,et al.  Immunoreactive pancreatic polypeptide (PP) occurs in the central and peripheral nervous system: Preliminary immunocytochemical observations , 1979, Cell and Tissue Research.

[3]  P. Halban,et al.  Functional differences between rat islets of ventral and dorsal pancreatic origin. , 1982, The Journal of clinical investigation.

[4]  A. Renold,et al.  Abnormalities of Pancreatic Somatostatin Secretion Corrected by In Vivo Insulin Treatment of Streptozotocin-Diabetic Rats , 1981, Diabetes.

[5]  D. Coy,et al.  Human pancreatic polypeptide inhibits insulin release in the rat. , 1981, Biochemical and biophysical research communications.

[6]  C. Wollheim,et al.  Glucose and Cyclic AMP as Stimulators of Somatostatin and Insulin Secretion From the Isolated, Perfused Rat Pancreas: A Quantitative Study , 1981, Diabetes.

[7]  S. Konturek,et al.  Difference in the action of human pancreatic polypeptide (PP) and its C-terminal hexapeptide on pancreatic secretion in man and dog , 1980, Regulatory Peptides.

[8]  T. Hökfelt,et al.  Coexistence of an avian pancreatic polypeptide (APP) immunoreactive substance and catecholamine in some peripheral and central neurons. , 1980, Acta physiologica Scandinavica.

[9]  Y. Seino,et al.  Effects of Insulin and Pancreatic Polypeptide on Gastric Somatostatin Release , 1980, Diabetes.

[10]  S. Falkmer,et al.  Gut-islet endocrinology-some evolutionary aspects. , 1980, Investigative & cell pathology.

[11]  R. H. Williams,et al.  Effects of cholecystokinin, secretin, and pancreatic polypeptide on secretion of gastric inhibitory polypeptide, insulin, and glucagon. , 1979, Life sciences.

[12]  A. Arimura,et al.  Suppression of somatostatin levels in the hepatic portal and systemic plasma of the rat by synthetic human pancreatic polypeptide. , 1979, Biochemical and biophysical research communications.

[13]  J. Walsh,et al.  Pancreatic polypeptide. Metabolism and effect on pancreatic secretion in dogs. , 1979, Gastroenterology.

[14]  F. Sundler,et al.  Somatostatin, pancreatic polypeptide, substance P, and neurotensin: cellular distribution and effects on stimulated insulin secretion in the mouse. , 1979, Endocrinology.

[15]  J. H. Baron,et al.  INHIBITION OF PANCREAS AND GALLBLADDER BY PANCREATIC POLYPEPTIDE , 1978, The Lancet.

[16]  R. Chance,et al.  Bovine pancreatic peptide: action on gastric and pancreatic secretion in dogs. , 1977, The American journal of physiology.

[17]  E. Samols,et al.  Remarkable potency of somatostatin as a glucagon suppressant. , 1976, Metabolism: clinical and experimental.

[18]  R. Chance,et al.  A newly recognized pancreatic polypeptide; plasma levels in health and disease. , 1976, Recent progress in hormone research.

[19]  P. Lacy,et al.  The use of ficoll in the preparation of viable islets of langerhans from the rat pancreas. , 1973, Transplantation.

[20]  F. Wolff,et al.  A Rat Pancreas-Small Gut Preparation for the Study of Intestinal Factor(s) and Insulin Release , 1969, Diabetes.

[21]  P. Lacy,et al.  Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas , 1967, Diabetes.